Profiling Microglia in a Mouse Model of Machado-Joseph Disease

Ana Bela Campos1,2, Sara Duarte-Silva1,2, Bruno Fernandes3

  • 1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.

Biomedicines
|February 25, 2022
PubMed

Insights

Researchers explored microglia, the brain's immune cells, in Machado-Joseph disease (MJD). They identified a unique MJD microglia profile with altered activation and specific gene changes, offering potential therapeutic targets for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Microglia are increasingly linked to neurodegenerative diseases (NDs).
  • Specific disease-associated microglia (DAM) profiles are known for some NDs.
  • The microglial profile in Machado-Joseph disease (MJD) was previously uncharacterized.

Purpose of the Study:

  • To characterize the microglial profile in a mouse model of Machado-Joseph disease (MJD).
  • To identify molecular perturbations and potential therapeutic targets in MJD-associated microglia.

Main Methods:

  • Utilized primary microglial cultures and cells from relevant brain regions of CMVMJD135 MJD mouse models.
  • Applied machine learning for morphological analysis of microglia.
  • Conducted RNA-sequencing to identify molecular changes.

Main Results:

  • Identified morphological alterations indicating increased microglial activation in MJD mice.
  • Defined a disease-specific transcriptional profile for MJD microglia, with 101 differentially expressed genes.
  • Found enrichment in pathways related to oxidative stress, immune response, cell proliferation, cell death, and lipid metabolism.

Conclusions:

  • Established the cellular and molecular profile of MJD-associated microglia.
  • Identified potential therapeutic targets for Machado-Joseph disease based on gene and pathway analysis.

Related Concept Videos